162 related articles for article (PubMed ID: 31163029)
1. Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study.
Al-Jebari Y; Glimelius I; Berglund Nord C; Cohn-Cedermark G; Ståhl O; Tandstad T; Jensen A; Sagstuen Haugnes H; Daugaard G; Rylander L; Giwercman A
PLoS Med; 2019 Jun; 16(6):e1002816. PubMed ID: 31163029
[TBL] [Abstract][Full Text] [Related]
2. Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.
Tandstad T; Solberg A; Håkansson U; Stahl O; Haugnes HS; Oldenburg J; Dahl O; Kjellman A; Angelsen A; Cohn-Cedermark G;
Acta Oncol; 2015 Apr; 54(4):493-9. PubMed ID: 25192551
[TBL] [Abstract][Full Text] [Related]
3. Risk of Congenital Malformations in Children Born Before Paternal Cancer.
Al-Jebari Y; Rylander L; Ståhl O; Giwercman A
JNCI Cancer Spectr; 2018 Apr; 2(2):pky027. PubMed ID: 31360856
[TBL] [Abstract][Full Text] [Related]
4. A study of children, fathered by men treated for testicular cancer, conceived before, during, and after chemotherapy.
Babosa M; Baki M; Bodrogi I; Gundy S
Med Pediatr Oncol; 1994; 22(1):33-8. PubMed ID: 8232078
[TBL] [Abstract][Full Text] [Related]
5. Sexual function in men treated for testicular cancer.
Eberhard J; Ståhl O; Cohn-Cedermark G; Cavallin-Ståhl E; Giwercman Y; Rylander L; Eberhard-Gran M; Kvist U; Fugl-Meyer KS; Giwercman A
J Sex Med; 2009 Jul; 6(7):1979-89. PubMed ID: 19453896
[TBL] [Abstract][Full Text] [Related]
6. Paternity through use of assisted reproduction technology in male adult and childhood cancer survivors: a nationwide register study.
Kitlinski M; Giwercman A; Elenkov A
Hum Reprod; 2023 May; 38(5):973-981. PubMed ID: 36773319
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for testicular cancer--differences between pure non-seminoma and mixed seminoma/non-seminoma?
Aschim EL; Haugen TB; Tretli S; Daltveit AK; Grotmol T
Int J Androl; 2006 Aug; 29(4):458-67. PubMed ID: 16487404
[TBL] [Abstract][Full Text] [Related]
8. Children fathered by men treated for testicular cancer.
Senturia YD; Peckham CS; Peckham MJ
Lancet; 1985 Oct; 2(8458):766-9. PubMed ID: 2864495
[TBL] [Abstract][Full Text] [Related]
9. Testicular cancer risk according to county of birth and county of diagnosis in Norway, 1958-2007.
Kvammen O; Tretli S; Johannessen TB; Klepp O; Grotmol T
Acta Oncol; 2012 Feb; 51(2):177-84. PubMed ID: 22248063
[TBL] [Abstract][Full Text] [Related]
10. Neonatal outcome and congenital malformations in children born after ICSI with testicular or epididymal sperm: a controlled national cohort study.
Fedder J; Loft A; Parner ET; Rasmussen S; Pinborg A
Hum Reprod; 2013 Jan; 28(1):230-40. PubMed ID: 23154066
[TBL] [Abstract][Full Text] [Related]
11. Familial coaggregation of cryptorchidism, hypospadias, and testicular germ cell cancer: a nationwide cohort study.
Schnack TH; Poulsen G; Myrup C; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Feb; 102(3):187-92. PubMed ID: 20026812
[TBL] [Abstract][Full Text] [Related]
12. Congenital malformations and testicular germ cell tumors.
Trabert B; Zugna D; Richiardi L; McGlynn KA; Akre O
Int J Cancer; 2013 Oct; 133(8):1900-4. PubMed ID: 23580254
[TBL] [Abstract][Full Text] [Related]
13. Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism.
Starr JR; Chen C; Doody DR; Hsu L; Ricks S; Weiss NS; Schwartz SM
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2183-90. PubMed ID: 16172230
[TBL] [Abstract][Full Text] [Related]
14. The risks of birth defects and childhood cancer with conception by assisted reproductive technology.
Luke B; Brown MB; Wantman E; Schymura MJ; Browne ML; Fisher SC; Forestieri NE; Rao C; Nichols HB; Yazdy MM; Gershman ST; Sacha CR; Williams M; Ethen MK; Canfield MA; Doody KJ; Eisenberg ML; Baker VL; Williams C; Sutcliffe AG; Richard MA; Lupo PJ
Hum Reprod; 2022 Oct; 37(11):2672-2689. PubMed ID: 36112004
[TBL] [Abstract][Full Text] [Related]
15. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells.
Camacho-Moll ME; Macdonald J; Looijenga LHJ; Rimmer MP; Donat R; Marwick JA; Shukla CJ; Carragher N; Jørgensen A; Mitchell RT
BMC Cancer; 2019 Nov; 19(1):1124. PubMed ID: 31744479
[TBL] [Abstract][Full Text] [Related]
16. Serum organochlorine pesticide residues and risk of testicular germ cell carcinoma: a population-based case-control study.
Biggs ML; Davis MD; Eaton DL; Weiss NS; Barr DB; Doody DR; Fish S; Needham LL; Chen C; Schwartz SM
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2012-8. PubMed ID: 18708392
[TBL] [Abstract][Full Text] [Related]
17. Parental occupational exposures in wood-related jobs and risk of testicular germ cell tumours in offspring in NORD-TEST a registry-based case-control study in Finland, Norway, and Sweden.
Corbin S; Togawa K; Schüz J; Le Cornet C; Fervers B; Feychting M; Wiebert P; Hansen J; Dalton SO; Kjærheim K; Nordby KC; Østrem RS; Skakkebæk NE; Uuksulainen S; Pukkala E; Olsson A
Int Arch Occup Environ Health; 2022 Aug; 95(6):1243-1253. PubMed ID: 34853884
[TBL] [Abstract][Full Text] [Related]
18. Sperm DNA integrity in testicular cancer patients.
Ståhl O; Eberhard J; Jepson K; Spano M; Cwikiel M; Cavallin-Ståhl E; Giwercman A
Hum Reprod; 2006 Dec; 21(12):3199-205. PubMed ID: 16931803
[TBL] [Abstract][Full Text] [Related]
19. An oncofetal and developmental perspective on testicular germ cell cancer.
Rijlaarsdam MA; Looijenga LH
Semin Cancer Biol; 2014 Dec; 29():59-74. PubMed ID: 25066859
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
